vimarsana.com
Home
Live Updates
Md Asan Medical Center - Breaking News
Pages:
Latest Breaking News On - Md asan medical center - Page 1 : vimarsana.com
Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80
The data provide evidence of another safe and effective stent in cases with shortened DAPT use, says Pieter Smits.
Soult ukpyolsi
South korea
New york
United states
Republic of korea
Ajay kirtane
Supraflex cruz
Pieter smits
Margaret mcentegart
Robert byrne
Presbyterian columbia university irving medical center
Phd mater private network
Md asan medical center
Maasstad hospital
Enriched patient
Columbia university irving medical center
OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions
These findings, from a prespecified analysis of OCTIVUS, should be considered hypothesis-generating, the researchers say.
South korea
Soult ukpyolsi
Republic of korea
Kyoon kang
Ziad ali
Md asan medical center
Francis hospital heart center
Journal of the american college cardiology
Do yoon kang
Asan medical center
American college
Francis hospital
Heart center
Routine Functional Testing Unnecessary After Stenting: POST-PCI
The trial, though negative, provides value for physicians by demonstrating what not to do after PCI, Davide Capodanno says.
New york
United states
Soult ukpyolsi
South korea
Republic of korea
Davide capodanno
European society of cardiology congress
Phd university of catania
Md asan medical center
Duk woo park
Asan medical center
European society
Cardiology congress
New england journal
Icahn school
Mount sinai
FFR s Future: Negative Trials Spur Debate Over Technology s Role
Some say it still has a niche, albeit smaller in light of recent studies, but as a means to defer not justify a stent.
United states
Soult ukpyolsi
South korea
United kingdom
City of
University of texas
William fearon
Kevin bainey
Sukhjinder nijjer
Lance gould
Los angeles
William boden
Rushi parikh
Phd imperial college london
Md asan medical center
Journal of the american college cardiology
vimarsana © 2020. All Rights Reserved.